alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.16


 


November 13, 2008


 


Maninder Hora


[***]


[***]


 


Dear Maninder:


 


On behalf of Facet Biotech Corporation, I am pleased to extend to you
an employment offer for the position of VP,
Product Operations & Quality, reporting to Faheem Hasnain, President and CEO effective December 1, 2008.


 


The bi-weekly base salary for this position will be $11,313.46 ($294,150
on an annualized basis) which will be paid in accordance with Facet Biotech’s
payroll procedures.   We offer our
employees an attractive benefits package, including comprehensive medical and
dental plans, and life insurance coverage, in addition to a competitive bonus
program, all of which you will be eligible for in accordance with the terms of
those plans and programs.


 


For purposes of federal immigration law, you are required to provide to
Facet Biotech documentary evidence of your identity and eligibility for
employment in the United States. 
Information related to what type of documentation qualifies is included
in your information packet. You must provide such documentation to us within
three business days of your date of hire.


 


Your employment with Facet Biotech will not be for a set term and you
will at all times be employed as an at-will employee. As an at-will employee
you will be free to resign at any time, just as Facet Biotech will be free to
terminate your employment at any time, with or without cause.  There will be no express or implied
agreements to the contrary.


 


Our offer of employment to you is contingent upon the successful completion
of our background check.  If Facet does
not already have a background check for you, we will perform one.


 


To indicate your acceptance of this offer, please sign and date this
letter in the space provided below and return it to the Human Resources Department,
along with the other required paperwork you received in your information
packet.  This offer letter supersedes any
prior representations or agreements, whether written or oral, with respect to
our offer of employment to you.  This
letter may not be modified or amended except by a written agreement, signed by
Facet Biotech and you.


 

















 


We are very excited at the prospect of your joining Facet Biotech as a
key contributor. This offer will remain open until December 1, 2008, at
which time it will expire if not previously accepted.


 


Sincerely,


 


Facet Biotech


 


 


	
  /s/ Gwen Carscadden

  	
   

  	
  I accept all of the terms above.

  
	
  Gwen
  Carscadden

  	
   

  	
   

  
	
  Director of Human Resources

  	
   

  	
  /s/ Maninder Hora

  
	
   

  	
   

  	
  Maninder Hora

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  November 14, 2008 

  
	
   

  	
   

  	
  Date
**OFFICE OF**  **THE ATTORNEY**  **GENERAL OF**  **TEXAS**

**GROVER SELLERS**  

### AUST’N 11 AITORW~Y

**GCNIIIAL**



### Henorrblo L. W. Vuice County ~Attmraey tltur County Box 207 

### Bit. Pleasant, Tour 

### Dear Sir: opinha Ho. 0-6750



### af the Amed

.~.

.’ .,Ar 

### trcii 1939; YJ’i tie 

### 4X, ctxijlter 2, Stat&s:‘01 **Texa,s; ‘**  **>**,:9’25, :+?9i aa follovr: **of** the Tievised ClvLl

“Each boun~g clerk shall record in h well bound beck the of~lcl~l dlschnrse of each s,oldler, sailor or other,~ersar, reeldent Ln the county vt:o served .ct hoqe or abroad ln the army o? navy forces of the United **-$&ate8** ln the late World War‘

. **For** such eervices raid clerk shall be alloved by **the commlsalonera**  **court, out**  ai the genenl fund of **the ceuntr,**  **net to**  exceed **fifteen** cents for each one hundred vords so recorded.”

### 685

Hon. L. V. **Vance,** pogo 2

This l totute (Article 

### 1939) woo amended b Ii. B. He. 109, Chop. 107, p. 187, Acts of thr 48th L 

### Sectlen 1, Regular &ooIea, 1943, l o l8 to read 40 f*llevo~ egloloture,
“Xoch Count7 Clerk l boll recerd In l roll-bound bemk the oiflclal 

### dlochorge of each 

### member of the Amed 

### Feroeo of the Waited Stator of kerlca 

### or the Armed Force 

### Reserve ai the Waited Water of America 

### or the Auxllla~ et l

lthor Amed Forces of the United Rteteo l 

### f 

### Americaor the Amed Ferce 

### Reserve of America 

### vho hove served In the Amed Forces l S the Waited **States** of kerica

liaoo 

### 1916. Than oboll bo no 

### ,ohrrgomode 

### for the 

### recording md keeping l

f the88 reoerdo. ” It vi11 be l

boerved tht Artlolo 1939 [As rmeaded br the Acts OS the 48tb LogIoloture)~ev,i~o t&t there l bol be 

### no charm medo fw 

### the recemlins: Dinn Of td UaderooorIag 

### ours

1 When l 

### otrtute, 01~11 or orl8Iao1, IO 

### l rprrooed la plain and uaublgueuo lmgmge, aad its meuilng 

### IO 

### olear &ad 

### l bvleuo, them IO **ao room**  **fer** 

### conotruotlrn. Caddy **~6. First**  Rotleaol Beak of Bee-eat, 

### 283 S. W. 4721 Sporko 

### ~8. Stab, 174 3. If. 331.

The lffr otive

dote of the above oat voo April 

### 6, 1943, aad llaoe

sold 

### date the forego ?n pre~loleao hove governed the subject utter inquired l beut

. rlrv

l 

### f the plain 

### pnrIoleao l f the oktute, It IO cur 

### l plnlea tUt the ComIoolenen~ **Court** l f 

### Titus Ceuaty ho am 

### l utherlty to ollev my roes cblmed by the Couaty Clerk 

### for recording and 

### keeping dloobmgeo of members of the Awed Forces or Reoervro. **Vary** 

### truly yours, 

### ATTORHBY

OERERAL

OF TEXAS
# Supreme Court of Texas

══════════ No. 23

- 0032

══════════
Weekley Homes, LLC,

Petitioner

,

v.
John Paniagua; and Hermelinda Maravilla Corona

, Jose Camerino Maravilla, Sr., and Margarita Maravilla, Individually and as Personal Representatives of the Estate of

Jose Camerino Maravilla, Deceased, et al.,

Respondent s

═══════════════════════════════════════

On Petition for Review from the Court of Appeals for the Fifth District o f Texas

═══════════════════════════════════════

JUDGMENT

THE SUPREME COURT OF TEXAS, having heard this cause on petition for
review from the Court of Appeals for the Fifth District, and having considered the
appellate record and counsels’ briefs, but without hearing oral argument under Texas
Rule of Appellate Procedure 59.1 , concludes that the court of appeals’ judgment

should be reversed in part

. IT IS THEREFORE ORDERED, in accordance with the Court’s opinion, that:

1) The portion of the court of appeals ’ judgment reversing the trial court’s judgment as to Respondents’ negligence and premises

- liability claims is reversed ; 2) The case is remanded to the court of appeals for further proceedings ; and
3) Petitioner shall recover, and Respondent s shall pay, the cost s incurred by Petitioner in this Court

.Copies of this judgment and the Court’s opinion are certified to the Court of

Appeals for the Fifth District and the 298th District Court of Dallas County , Texas,

for observance.
Opinion of the Court delivered Per Curiam

.

June 21 , 2024

**********
<PAGE>   1
                                                                      Exhibit 23
                                                                                


                        Consent of Independent Auditors

We consent to the incorporation by reference in the Registration Statement (Form
S-8 No. 33-17030) pertaining to the 1986 Stock Option Plan; in the Registration
Statements (Forms S-8 No. 33-68676, No. 33-24122, No. 33-30716 and No.
333-17259) pertaining to the 1988 Stock Option Plan; in the Registration
Statement (Form S-8 No. 333-59861) pertaining to the 1997 Stock Option Plan; in
the Registration Statements (Forms S-8 No. 33-68476 and No. 333-71971)
pertaining to the Stock Option Plan for Nonemployee Directors; and in the
Registration Statements (Forms S-3 No. 333-28139,  No. 333-29171, No. 333-45803
and No. 333-69317 and Form S-4 No. 33-06901) and in the related Prospectuses of
Duramed Pharmaceuticals, Inc. of our report dated March 29, 1999 with respect to
the consolidated financial statements and schedule of Duramed Pharmaceuticals,
Inc. included in this Annual Report (Form 10-K) for the year ended December 31,
1998.

                                                               ERNST & YOUNG LLP

Cincinnati, Ohio
March 29, 1999
# United States Court of Appeals

For the Seventh Circuit

Chicago, Illinois 60604

February 16, 2018

Before

MICHAEL S. KANNE, Circuit Judge

DIANE S. SYKES, Circuit Judge

DAVID F. HAMILTON, Circuit Judge

No. 15

‐ 2138

KELVIN NORWOOD,

Plaintiff

‐ Appellant

,

v

.

PARTHASARATHI GHOSH, et al.,

Defendants

‐ Appellees

. Appeal from the United States District

Court for the Northern District of Illinois,

Eastern Division.

No. 11

‐ CV

‐ 988

Charles R. Norgle

, J udge

.

O R D E R

The court hereby AMENDS the first sentence on page 5 of the order issued on

January 26, 2018, to read as follows: Norwood saw the outside orthopedic surgeon, Dr.

Samuel Chmell, on November 23, 2009.
Anthony LAZZARONI, Appellant, v. STATE of Florida, Appellee.

Case No. 5D17-2594

District Court of Appeal of Florida, Fifth District.

Decision filed February 20, 2018 Rehearing Denied April 12, 2018

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
Richard L. AUDIN, Appellant(s)/Petitioner(s), v. US BANK NATIONAL ASSOCIATION, Appellee(s)/Respondent(s),

CASE NO.: 3D17-1380

District Court of Appeal of Florida, Third District.

SEPTEMBER 28, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1444 Enrolled Bill (ENR)]

        H.R.1444

                    One Hundred Seventeenth Congress

                                 of the

                        United States of America

                          AT THE SECOND SESSION

           Begun and held at the City of Washington on Monday,
          the third day of January, two thousand and twenty-two

                                 An Act

 
To designate the facility of the United States Postal Service located at 
   132 North Loudoun Street, Suite 1 in Winchester, Virginia, as the 
                      ``Patsy Cline Post Office''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,
SECTION 1. PATSY CLINE POST OFFICE.
    (a) Designation.--The facility of the United States Postal Service 
located at 132 North Loudoun Street, Suite 1 in Winchester, Virginia, 
shall be known and designated as the ``Patsy Cline Post Office''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``Patsy 
Cline Post Office''.

                               Speaker of the House of Representatives.

                            Vice President of the United States and    
                                               President of the Senate.
```
#### Rector vs. Harris, Norton & Co.

A writ of error will not lie to the original judgment, where an execution has been issued on it, a delivery bond given and forfeited, and so returned by the sheriff (14 *Ark.*595, 597.)

*Error to the Circuit Court of Pulaski County.*

Garland, for the plaintiff.

Watkins & Gallagher, for the defendants.

*266Mr. Justice Scott

delivered the opinion of the Court. •

To the writ of error in this case, the defendants in error interposed a plea, setting up that a writ of execution was issued upon the judgment herein, which was levied upon property and a forthcoming bond given and forfeited, and so returned by the sheriff. To which plea there was a demurrer and joinder. As heretofore several times held in this Court, under such circumstances, a writ of error does not lie to the original judgment. *(Phillips et al. vs. Wills, Pease*& *Co.,*14 *Ark. R.*595; *Daugherty vs.. McDonald, ib.*597, *and other cases since decided.*

The demurrer will therefore be, overruled, and the writ of error quashed at the costs of the plaintiff in error. .

Absent, Mr. Justice Hanly.
Exhibit 32.1

                                  Certification
                       pursuant to 18 U.S.C. Section 1350,
                             as adopted pursuant to
                  Section 906 of the Sarbanes-Oxley Act of 2002
      --------------------------------------------------------------------

In connection  with the Quarterly  Report Pursuant to Section 13 or 15(d) of the
Securities  Exchange Act of 1934 on Form 10-Q of Immtech  Pharmaceuticals,  Inc.
(the "Company") for the quarterly  period ended June 30, 2006, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Eric L.
Sorkin, President and Chief Executive Officer of the Company,  certify, pursuant
to  18  U.S.C.  Section  1350,  as  adopted  pursuant  to  Section  906  of  the
Sarbanes-Oxley Act of 2002, that:

        1)     the Report fully complies with the  requirements of Section 13(a)
               or 15(d) of the Securities Exchange Act of 1934, as amended; and

        2)     the information  contained in the Report fairly presents,  in all
               material  respects,   the  financial  condition  and  results  of
               operations of the Company.

                            /s/ Eric L. Sorkin
                            ------------------
                            Eric L. Sorkin
                            President & Chief Executive Officer
                            August 9, 2006
Marco Manuel TORRES, Petitioner, v. Craig LATIMER, Hillsborough County Supervisor of Elections, Respondent.

Case No. 2D17-2739

District Court of Appeal of Florida, Second District.

Opinion filed March 23, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Denied.
##### 



EXHIBIT 32.1 CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Each of the undersigned hereby certifies, in his capacity as an officer of Stater Bros. Holdings
Inc. (the Company), for purposes of 18 U.S.C. Section 1350, as adopted pursuant to section 906 of
the Sarbanes-Oxley Act of 2002, that to his knowledge:  
    the Quarterly Report of the Company on Form 10-Q for the period ended December 26,
2004 fully complies with the requirements of Section 13(a) and 15(b) of the Securities
Exchange Act of 1934; and  
    the information contained in the Form 10-Q fairly presents, in all material
respects, the financial condition and results of operation of the Company. Date: February 9, 2005 /s/ Jack H. Brown
Jack H. Brown
Chairman, President, and
Chief Executive Officer
(Principal Executive Officer)
February 9, 2005 /s/ Phillip J. Smith
Phillip J. Smith
Senior Vice President, and
Chief Financial Officer
(Principal Financial Officer)
February 9, 2005
Exhibit 31.2

I, Gary C. Parks, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Immtech International,
Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;

(b) Evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and

(c) Disclosed in this report any change in the registrant's internal control
over financial reporting that occurred during the registrant's most recent
fiscal quarter that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial reporting;
and

5. The registrant's other certifying officer(s) and I have disclosed, based on
our most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of
directors:

(a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control over
financial reporting.

Date: February 17, 2004

/s/ Gary C. Parks
----------------------------
   Gary C. Parks
   Chief Financial Officer
IA 

117TH CONGRESS 

1ST SESSION H. J. RES. 25 

Disapproving the action of the District of Columbia Council in approving 

the Minor Consent for Vaccinations Amendment Act of 2020. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 11, 2021 

Mr. CLOUD (for himself, Mr. PALMER, Mr. DUNCAN, Mr. LAMALFA, Mr. 

POSEY, Mr. JORDAN, and Mr. BABIN) submitted the following joint resolution; which was referred to the Committee on Oversight and Reform 

JOINT RESOLUTION 

Disapproving the action of the District of Columbia Council 

in approving the Minor Consent for Vaccinations Amendment Act of 2020. 

1 Resolved by the Senate and House of Representatives

2 of the United States of America in Congress assembled, 

3 That the Congress disapproves of the action of the District 

4 of Columbia Council described as follows: The Minor Con5 sent for Vaccinations Amendment Act of 2020 (D.C. Act 

6 23–532), enacted by the Council of the District of Colum7 bia on December 23, 2020, and transmitted to Congress 


pamtmann on DSKBC07HB2PROD with BILLS
2 

•HJ 25 IH 

1 pursuant to section 602(c)(1) of the District of Columbia 

2 Home Rule Act on February 1, 2021. 

Æ 


pamtmann on DSKBC07HB2PROD with BILLS
Exhibit 23


               CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS


Bestnet Communications, Inc.
Grand Rapids, Michigan

As independent  public  accountants,  we hereby consent to the  incorporation by
reference in the S-2  registration  statement  of our report  dated  October 19,
2001,  included in the  Company's  Form  10-KSB/A  for the year ended August 31,
2001, and to all references to our firm included in this registration  statement
and the amended Form 10-KSB/A filing.


                                        /s/ SEMPLE & COOPER, LLP


Phoenix, Arizona
October 3, 2002
Bruce BALKEY, Appellant, v. GULFSTREAM PARK RACING ASSOCIATION, INC., Appellee.

No. 4D17-943

District Court of Appeal of Florida, Fourth District.

[March 29, 2018]

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
In the United States Court of Federal Claims 

OFFICE OF SPECIAL MASTERS

No. 13-680V

Filed: June 11, 2014

Not for Publication

*************************************

LISA GLADSTONE, *

*

 Petitioner, * Attorneys’ fees and costs decision based on

 * stipulation of fact

v. *

 *

SECRETARY OF HEALTH *

AND HUMAN SERVICES, *

 *

 Respondent. *

*

*************************************

Mindy M. Roth, Glen Rock, NJ, for petitioner.

Justine E. Daigneault, Washington, DC, for respondent.

MILLMAN, Special Master

DECISION AWARDING ATTORNEYS’ FEES AND COSTS1

On June 11, 2014, the parties filed a stipulation of fact in which they agreed on an 

appropriate amount for attorneys’ fees and costs in this case.

In accordance with the General Order #9 requirement, petitioner asserts that she did not 

incur any out-of-pocket expenses in pursuit of her petition. Petitioner submitted her request for 

attorneys’ fees and costs to respondent. Petitioner requests reimbursement for attorneys’ fees and 

costs in the amount of $12,441.61. Respondent does not object to this amount. The undersigned 

 

1 Because this unpublished decision contains a reasoned explanation for the special master’s action in this 

case, the special master intends to post this unpublished decision on the United States Court of Federal 

Claims’s website, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, 116 Stat. 2899, 

2913 (Dec. 17, 2002). Vaccine Rule 18(b) states that all decisions of the special masters will be made 

available to the public unless they contain trade secrets or commercial or financial information that is 

privileged and confidential, or medical or similar information whose disclosure would constitute a clearly 

unwarranted invasion of privacy. When such a decision is filed, petitioner has 14 days to identify and 

move to redact such information prior to the document=s disclosure. If the special master, upon review, 

agrees that the identified material fits within the banned categories listed above, the special master shall 

redact such material from public access.
2

finds this amount to be reasonable. Accordingly, the court awards $12,441.61, representing 

reimbursement for attorneys’ fees and costs. The award shall be in the form of a check made 

payable jointly to petitioner and Britcher, Leone & Roth, LLC in the amount of $12,441.61.

In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the 

court is directed to enter judgment herewith.2

IT IS SO ORDERED.

Dated: June 11, 2014 s/ Laura D. Millman

 Laura D. Millman

 Special Master

 

2

Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party, either separately or 

jointly, filing a notice renouncing the right to seek review.